Castle Biosciences Statistics
Total Valuation
CSTL has a market cap or net worth of $563.05 million. The enterprise value is $324.47 million.
Important Dates
The last earnings date was Monday, August 4, 2025, after market close.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSTL has 29.01 million shares outstanding. The number of shares has increased by 4.13% in one year.
Current Share Class | 29.01M |
Shares Outstanding | 29.01M |
Shares Change (YoY) | +4.13% |
Shares Change (QoQ) | +3.27% |
Owned by Insiders (%) | 2.88% |
Owned by Institutions (%) | 92.56% |
Float | 26.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.59 |
Forward PS | 1.95 |
PB Ratio | 1.24 |
P/TBV Ratio | 1.60 |
P/FCF Ratio | 16.30 |
P/OCF Ratio | 9.01 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 16.69, with an EV/FCF ratio of 9.39.
EV / Earnings | n/a |
EV / Sales | 0.94 |
EV / EBITDA | 16.69 |
EV / EBIT | n/a |
EV / FCF | 9.39 |
Financial Position
The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.08.
Current Ratio | 6.85 |
Quick Ratio | 6.47 |
Debt / Equity | 0.08 |
Debt / EBITDA | 1.66 |
Debt / FCF | 1.08 |
Interest Coverage | -69.64 |
Financial Efficiency
Return on equity (ROE) is -2.15% and return on invested capital (ROIC) is -3.06%.
Return on Equity (ROE) | -2.15% |
Return on Assets (ROA) | -2.79% |
Return on Invested Capital (ROIC) | -3.06% |
Return on Capital Employed (ROCE) | -4.67% |
Revenue Per Employee | $455,018 |
Profits Per Employee | -$12,439 |
Employee Count | 761 |
Asset Turnover | 0.67 |
Inventory Turnover | 8.03 |
Taxes
Income Tax | -781,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.44% in the last 52 weeks. The beta is 1.09, so CSTL's price volatility has been similar to the market average.
Beta (5Y) | 1.09 |
52-Week Price Change | -27.44% |
50-Day Moving Average | 18.35 |
200-Day Moving Average | 23.10 |
Relative Strength Index (RSI) | 58.62 |
Average Volume (20 Days) | 681,166 |
Short Selling Information
The latest short interest is 1.40 million, so 4.82% of the outstanding shares have been sold short.
Short Interest | 1.40M |
Short Previous Month | 1.41M |
Short % of Shares Out | 4.82% |
Short % of Float | 5.26% |
Short Ratio (days to cover) | 3.77 |
Income Statement
In the last 12 months, CSTL had revenue of $346.27 million and -$9.47 million in losses. Loss per share was -$0.33.
Revenue | 346.27M |
Gross Profit | 280.47M |
Operating Income | -23.05M |
Pretax Income | -4.02M |
Net Income | -9.47M |
EBITDA | 19.44M |
EBIT | -23.05M |
Loss Per Share | -$0.33 |
Full Income Statement Balance Sheet
The company has $275.93 million in cash and $37.35 million in debt, giving a net cash position of $238.58 million or $8.22 per share.
Cash & Cash Equivalents | 275.93M |
Total Debt | 37.35M |
Net Cash | 238.58M |
Net Cash Per Share | $8.22 |
Equity (Book Value) | 455.38M |
Book Value Per Share | 15.71 |
Working Capital | 297.78M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $62.49 million and capital expenditures -$27.95 million, giving a free cash flow of $34.54 million.
Operating Cash Flow | 62.49M |
Capital Expenditures | -27.95M |
Free Cash Flow | 34.54M |
FCF Per Share | $1.19 |
Full Cash Flow Statement Margins
Gross margin is 81.00%, with operating and profit margins of -6.66% and -2.73%.
Gross Margin | 81.00% |
Operating Margin | -6.66% |
Pretax Margin | -2.96% |
Profit Margin | -2.73% |
EBITDA Margin | 5.61% |
EBIT Margin | -6.66% |
FCF Margin | 9.97% |
Dividends & Yields
CSTL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.13% |
Shareholder Yield | -4.13% |
Earnings Yield | -1.68% |
FCF Yield | 6.13% |
Analyst Forecast
The average price target for CSTL is $37.67, which is 94.08% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $37.67 |
Price Target Difference | 94.08% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 3.23% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CSTL has an Altman Z-Score of 5.27 and a Piotroski F-Score of 4.
Altman Z-Score | 5.27 |
Piotroski F-Score | 4 |